Anyone who has ever gotten a health insurance denial letter has probably wondered exactly how that decision got made. A federal court just ordered one of the country’s largest insurers to answer that question in detail — at least when it comes to artificial intelligence.
What the court ordered
A federal judge denied UnitedHealth’s bid to limit the scope of discovery in a lawsuit alleging the company used an AI algorithm to systematically deny coverage for Medicare Advantage patients. According to Becker’s Payer Issues, the ruling means UnitedHealth must produce a broader set of records related to its AI-driven claims process than the company had argued should be required.
Law firm ArentFox Schiff’s client alert, Federal Court Orders Broad Discovery Against UHC in AI Coverage Denial Lawsuit, goes into more detail on the scope of what the court is requiring the insurer to hand over — a meaningful development given how much of the underlying dispute turns on exactly how the algorithm was built, trained, and applied to real patient cases. The Hunton Insurance Recovery Blog’s post, Court Allows Discovery Into Insurer’s Use of AI to Deny Claims, and a companion writeup at the National Law Review both frame the ruling as a significant win for plaintiffs’ ability to actually examine how the algorithm functions, rather than simply accepting the insurer’s characterization of it.
The road to this ruling
This discovery fight has been building for a while. Insurance trade outlet InsuranceNewsNet reported earlier this year that a judge gave UnitedHealth until April 29 to hand over AI claim denial documents, and ProgramBusiness has been tracking the underlying dispute in its coverage of how courts are examining AI discovery in a Medicare Advantage coverage decision case. The current ruling represents the latest — and broadest — step in that ongoing discovery process, not a final resolution of liability.
Why discovery scope matters so much in a case like this
In most insurance bad-faith or coverage-denial litigation, the central factual dispute is why a claim was denied — was it a legitimate, individualized medical judgment, or a systematic policy applied without real case-by-case review? When that judgment is made in part by an algorithm, plaintiffs generally need access to the algorithm’s design, training data, and error rates to make that case. A narrow discovery order can effectively end a case before it starts; a broad one, like the one just issued, gives plaintiffs’ counsel the material needed to actually test the insurer’s claims about how the system works.
Hunton’s Insurance Recovery Blog maintains an ongoing artificial intelligence category tracking similar disputes across the industry, which is worth bookmarking given how quickly this area of law is developing. A broader legal explainer, Insurance Industry’s Use of AI: A Fair or Unfair Claim Settlement Practice?, lays out the doctrinal question courts are increasingly being asked to answer: do existing state unfair-claims-settlement-practices statutes, written long before AI claims review existed, adequately govern this conduct at all?
Who should be watching this case
- Medicare Advantage enrollees and their families, since the underlying allegations go directly to coverage decisions affecting skilled nursing and rehabilitation care — exactly the kind of claims where denial timing has serious real-world consequences.
- Health insurance litigators and policyholder advocates, for whom this discovery order will likely become a citable precedent in similar AI-claims-denial suits against other insurers.
- Insurers using AI in claims adjudication generally, who should treat this ruling as a signal that courts are willing to look closely at algorithmic decision-making rather than treating it as a black box exempt from scrutiny.
For a broader primer on this emerging area, Humanoid Liability’s legal guide to AI healthcare claim denial litigation is a useful reference for readers who want more background on how these cases are typically structured.
The bottom line
This ruling doesn’t decide whether UnitedHealth’s AI system actually violated the law — that question is still ahead. But it does mean the public (through the litigation record) will get a far more detailed look at how AI-driven coverage decisions actually work than has typically been available, and it will likely shape how similar suits against other insurers are litigated going forward.
This post will be updated as document production proceeds and if any of the underlying records become part of the public docket.
